Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glywohn MP 2mg/500mg/15mg Tablet

Prescription Icon
Prescription Required

Marketer

Riyadh Pharmaceutical

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Glywohn MP 2mg/500mg/15mg Tablet

Diabetic patients with type 2 mellitus may find blood glucose management aided by Glywohn MP 2mg/500mg/15mg tablets, a combined medication. This treatment, used alongside diet and exercise, enhances insulin efficacy and reduces blood sugar. Dosage and frequency should strictly follow your physician's instructions; ingestion with food minimizes stomach discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose. Excessive intake risks hypoglycemia (low blood sugar). Concurrent use with other diabetes medication, alcohol, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is essential. Common side effects can encompass nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Kidney, liver, or heart conditions necessitate prior physician consultation, as should pregnancy or breastfeeding. Pre-treatment kidney function assessment is standard procedure. Limit alcohol consumption to mitigate potential adverse effects.

Uses of Glywohn MP 2mg/500mg/15mg Tablet

Managing type 2 diabetes

Major Benefits of Glywohn MP 2mg/500mg/15mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glywohn MP 2mg/500mg/15mg tablets with a meal.

Common Side effects of Glywohn MP 2mg/500mg/15mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Glywohn MP 2mg/500mg/15mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glywohn MP 2mg/500mg/15mg Tablets. Ingest the tablets whole; do not chew, crush, or fracture them. Administer this medication with food.

How Glywohn MP 2mg/500mg/15mg Tablet works:

Glywohn MP 2mg/500mg/15mg tablets combine the antidiabetic actions of glimepiride, metformin, and pioglitazone. This triple-drug approach offers superior blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glywohn MP 2mg/500mg/15mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glywohn MP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Patient consultation with their doctor is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Glywohn MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glywohn MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates use of this medication. Regular monitoring of renal function is recommended during treatment. Consult your physician for guidance.

LiverLiverCAUTION

Patients with hepatic impairment should use Glywohn MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glywohn MP 2mg/500mg/15mg tablets are contraindicated in individuals with severe liver dysfunction.

What if you forget to take Glywohn MP 2mg/500mg/15mg Tablet :

Should you forget a Glywohn MP 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glywohn MP 2mg/500mg/15mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glywohn MP 2mg/500mg/15mg Tablet

Consuming alcohol while taking Glywohn MP 2mg/500mg/15mg tablets is unsafe. Alcohol can cause low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Consult your doctor before using Glywohn MP 2mg/500mg/15mg Tablet if you have congestive heart failure, kidney or liver problems, or eye swelling. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and about all medications you take, including prescription and non-prescription drugs, vitamins, and herbal supplements.
Metformin, a component of Glywohn MP 2mg/500mg/15mg Tablet, can lead to vitamin B12 deficiency with prolonged use due to impaired absorption in the stomach.
Glywohn MP 2mg/500mg/15mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial, and carrying a sugary snack, such as candy or chocolate, is recommended.
Store this medication in its original, tightly closed container, as directed on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glywohn MP 2mg/500mg/15mg...
60
MRP 73
17% off